Correlation Between Bionoid Pharma and Smith Douglas

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bionoid Pharma and Smith Douglas at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bionoid Pharma and Smith Douglas into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bionoid Pharma and Smith Douglas Homes, you can compare the effects of market volatilities on Bionoid Pharma and Smith Douglas and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bionoid Pharma with a short position of Smith Douglas. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bionoid Pharma and Smith Douglas.

Diversification Opportunities for Bionoid Pharma and Smith Douglas

0.44
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Bionoid and Smith is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Bionoid Pharma and Smith Douglas Homes in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Smith Douglas Homes and Bionoid Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bionoid Pharma are associated (or correlated) with Smith Douglas. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Smith Douglas Homes has no effect on the direction of Bionoid Pharma i.e., Bionoid Pharma and Smith Douglas go up and down completely randomly.

Pair Corralation between Bionoid Pharma and Smith Douglas

Given the investment horizon of 90 days Bionoid Pharma is expected to under-perform the Smith Douglas. In addition to that, Bionoid Pharma is 6.55 times more volatile than Smith Douglas Homes. It trades about -0.02 of its total potential returns per unit of risk. Smith Douglas Homes is currently generating about -0.03 per unit of volatility. If you would invest  3,407  in Smith Douglas Homes on August 29, 2024 and sell it today you would lose (132.00) from holding Smith Douglas Homes or give up 3.87% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Bionoid Pharma  vs.  Smith Douglas Homes

 Performance 
       Timeline  
Bionoid Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Weak
Over the last 90 days Bionoid Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Smith Douglas Homes 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Smith Douglas Homes has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's technical indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Bionoid Pharma and Smith Douglas Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bionoid Pharma and Smith Douglas

The main advantage of trading using opposite Bionoid Pharma and Smith Douglas positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bionoid Pharma position performs unexpectedly, Smith Douglas can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Smith Douglas will offset losses from the drop in Smith Douglas' long position.
The idea behind Bionoid Pharma and Smith Douglas Homes pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Commodity Directory
Find actively traded commodities issued by global exchanges
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings